Skip to main content

Table 1 Schedule of events

From: Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

Visit

Screen

Baseline

Follow-up visits

Early termination visit/unscheduled study visit

Visit number

1

2

3

4

5

6

7

--

Day of visit

Up to day −7

1

2

5±2

8+1

11+7

30±7

Variable

Informed consent

X

       

Review eligibility criteria

X

X

      

Serum HCG pregnancy test

X

       

Urine pregnancy test

 

X

      

Demographics

X

       

Height and weight

X

       

Medical history

X

       

Medication history

X

       

Review of systems

X

X

X

X

X

X

X

X

Treatment assignment

 

X

      

Administration of study product

 

X

      

Concomitant medications

 

X

X

X

X

X

X

X

Physical examination

X

       

Symptom-directed physical examination

 

X

X

X

X

X

X

X

Vital signs

X

X

X

X

X

X

X

X

Spirometry

X

X

X

X

X

X

X

X

Sputum collection for microbiology and phage pharmocokinetics

X

X

X

X

X

X

X

X

Clinical chemistry

 

X

X

X

X

X

X

X

Liver function tests

X

X

X

X

X

X

X

X

Hematology

 

X

X

X

X

X

X

X

Serum for phage pharmacokinetics

 

X

X

     

Cystic Fibrosis Questionnaire-Revised (stage 2 only)

 

X

    

X

 

Cystic Fibrosis Respiratory Symptom Diary (stage 2 only)

 

X

X

X

X

X

X

X

Safety assessment

 

X

X

X

X

X

X

X

Events of special interest

 

X

X

X

X

  

X